Enteral feeding in duct-dependent congenital heart disease

T G Day1,2, D Dionisio1, D Zannino3

  • 1Department of Cardiology, The Royal Children's Hospital Melbourne, Parkville, VIC, Australia.

Insights

Necrotising enterocolitis (NEC) is a serious condition in infants with congenital heart defects. This study found no increased risk of NEC in infants receiving prostaglandin E1 when given enteral nutrition.

Area of Science:

  • Neonatalogy
  • Pediatric Cardiology
  • Gastroenterology

Background:

  • Infants with duct-dependent congenital heart lesions require prostaglandin E1 infusion for treatment.
  • Feeding strategies and the incidence of necrotising enterocolitis (NEC) in this vulnerable population are not well-defined.
  • Investigating the potential link between enteral feeding and NEC is crucial for optimizing infant care.

Purpose of the Study:

  • To describe feeding strategies in infants with duct-dependent congenital heart lesions.
  • To determine the incidence of NEC in these infants.
  • To assess the association between enteral feeding and NEC risk.

Main Methods:

  • Retrospective review of infants diagnosed with hypoplastic left heart syndrome, coarctation of the aorta, pulmonary atresia, or transposition of the great arteries.
  • Exclusion of premature infants, those with pre-existing GI disease, and those not receiving prostaglandin.
  • Univariable and multivariable logistic regression models for data comparison.

Main Results:

  • A total of 177 infants were identified.
  • 18 infants were diagnosed with suspected or confirmed NEC.
  • No statistically significant association was found between enteral feeding and NEC (P = 0.9).

Conclusions:

  • Enteral feeding does not appear to increase the risk of NEC in infants receiving prostaglandin E1.
  • These findings support the use of enteral feeding in this patient group.
  • Further research may explore optimal feeding protocols.
Abstract

Related Concept Videos

Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.5K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
519
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
361
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
332